GISSI-2: mortality plus extensive left-ventricular damage as "end-point"

Lancet. 1990 Feb 3;335(8684):289. doi: 10.1016/0140-6736(90)90104-d.
No abstract available

Publication types

  • Clinical Trial
  • Comparative Study
  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Algorithms
  • Heart Ventricles / injuries
  • Humans
  • Italy
  • Myocardial Infarction / drug therapy*
  • Myocardial Infarction / mortality
  • Randomized Controlled Trials as Topic
  • Streptokinase / therapeutic use*
  • Tissue Plasminogen Activator / therapeutic use*

Substances

  • Streptokinase
  • Tissue Plasminogen Activator